title: Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model.
abstract: One explanation for the clinical association between tumour vascularity and probability of metastasis is that increased primary tumour vascularity enhances haematogenous dissemination by offering greater opportunity for tumour cell invasion into the circulation (intravasation). We devised an experimental tumour metastasis model that allowed manipulation of primary tumour vascularity with differential exposure of the primary and metastatic tumour site to angiogenic agents. We used this model to assess the effects of local and systemic increases in the level of the angiogenic agent basic fibroblast growth factor on metastasis. BDIX rats with implanted hind limb K12/TR adenocarcinoma tumours received either intratumoural or systemic, basic fibroblast growth factor or saline infusion. Both intratumoural and systemic basic fibroblast growth factor infusion resulted in significant increases in tumour vascularity, blood flow and growth, but not lung metastasis, compared with saline-infused controls. Raised basic fibroblast growth factor levels and increase in primary tumour vascularity did not increase metastasis. The clinical association between tumour vascularity and metastasis is most likely to arise from a metastatic tumour genotype that links increased tumour vascularity with greater metastatic potential.
authors.affiliation: Division of Surgery, Faculty of Medicine, Imperial College School of Science, Technology and Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.
authors.forename: M M
authors.initials: MM
authors.lastname: Davies
authors.forename: P
authors.initials: P
authors.lastname: Mathur
authors.forename: P
authors.initials: P
authors.lastname: Carnochan
authors.forename: S
authors.initials: S
authors.lastname: Saini
authors.forename: T G
authors.initials: TG
authors.lastname: Allen-Mersh
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply* / Q000473:pathology / Q000556:secondary*; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000473:pathology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D008297:Male; D051381:Rats
chemical_list: D016222:Fibroblast Growth Factor 2